Adicet Bio Inc (NAS:ACET)
$ 1.44 -0.03 (-2.04%) Market Cap: 118.32 Mil Enterprise Value: -18.00 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 54/100

Adicet Bio Inc at Jefferies Cell Therapy Summit Transcript

Oct 05, 2020 / 06:30PM GMT
Release Date Price: $12.03 (+1.18%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Welcome, everyone, to the Jefferies Cell Therapy Summit. I'd like to welcome our next company. We have Adicet Bio, their CEO, Chen Schor; and their Chief Scientific Officer, Stewart Abbot. So welcome guys. We've got about 25 minutes. This is going to be a fireside chat format. (Operator Instructions).

Just for those that aren't familiar with Adicet, recently became public through a reverse merger. Maybe, Chen, just talk about high-level pipeline, objective in cell therapy, what you're hoping to accomplish and then we can go into specific programs.

Chen Schor
Adicet Bio, Inc. - CEO, President & Director

Absolutely. So first of all, Biren, thank you so much for inviting us. I mean, it's especially great to be here with your expertise in the field of cell therapy. So perhaps I'll give a brief background about gamma delta T cells and brief about the pipeline.

So yes -- gamma delta T cells, the first important piece of evidence actually comes from an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot